The New York Times 1999 David J. Morrow - Abstracts
| The New York Times 1999 David J. Morrow | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Investors study drug pipelines for the next blockbuster medicine.(Abstract) | Business, general | David J. Morrow | |||
| Lilly to stop developing migraine drug.(Eli Lilly & Co.)(Abstract) | Business, general | David J. Morrow | |||
| New profits in old bottles; companies find bonus in drugs that cure several ills.(Abstract) | Business, general | David J. Morrow | |||
| SmithKline to sell off units for $1.97 billion.(SmithKline Beecham PLC)(Abstract) | Business, general | David J. Morrow | |||
| Warner-Lambert to acquire Agouron Pharmaceuticals.(Abstract) | Business, general | David J. Morrow | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.